跳至主要内容
临床试验/ISRCTN10447645
ISRCTN10447645已完成未知

Quality-Assured Follow-up of quiEscent Neovascular agE-relaTed maculaR dEgeneration by non-medical practitioners: a randomised controlled trial

Moorfields Eye Hospital NHS Foundation Trust0 个研究点目标入组 707 人开始时间: 2018年9月26日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
707

研究概览

简要总结

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33980536/ (added 18/09/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Receiving treatment in nAMD injection clinics
  • 2. Reached agreed definition of disease quiescence
  • 3. Provided informed consent
  • 4. Aged 55 years or older
  • 5. Ability to perform study-specific procedures

排除标准

  • 1. Significant media opacities (cataracts, vitreous opacities) that do not allow good quality fundus imaging
  • 2. Diabetic retinopathy of severity worse than mild non-proliferative stage and with any degree of diabetic maculopathy
  • 3. History of other causes of choroidal neovascularisation (myopic, angoid streaks, inflammatory, retinal dystrophies, secondary to central serous chorioretinopathy, idiopathic)

研究者

相似试验